GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $296,000 | +2.1% | 9,219 | +3.4% | 0.04% | -10.2% |
Q2 2017 | $290,000 | +7.0% | 8,912 | +3.7% | 0.05% | 0.0% |
Q1 2017 | $271,000 | +11.5% | 8,595 | +4.1% | 0.05% | +2.1% |
Q4 2016 | $243,000 | +6.1% | 8,255 | +4.4% | 0.05% | +4.3% |
Q3 2016 | $229,000 | -4.6% | 7,910 | +16.0% | 0.05% | -20.7% |
Q4 2015 | $240,000 | – | 6,819 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |